文献速递脑血管病

急诊医师使用核查表准确选择急性卒中患者进行tPA治疗

Emergency Medicine Physicians Accurately Select Acute Stroke Patients for Tissue-Type Plasminogen Activator Treatment Using a Checklist.
PubMed 文献 · Stroke · 2019-11-27

本研究前瞻性纳入60例发病4.5小时内的疑似急性卒中患者,比较使用tPA筛查核查表的急诊住院医师与血管神经科专科医师在tPA治疗决策上的一致性。结果显示急诊医师与专科医师的一致性较高(κ=0.68),但卒中模拟病的识别是分歧的主要来源。

要点

  • 使用核查表时,急诊住院医师与血管神经科专科医师的tPA治疗决策一致性较高(κ=0.68)。
  • 卒中模拟病是治疗决策分歧的主要原因。
  • 研究提示核查表可辅助急诊医师准确选择tPA治疗患者。

核心结论

  • 使用核查表辅助,急诊住院医师可准确选择急性卒中患者进行tPA治疗。
  • 卒中模拟病的识别是需改进的领域。

研究设计与样本

  • 前瞻性研究,纳入60例发病4.5小时内的疑似急性卒中患者,由血管神经科专科医师与使用tPA筛查核查表的急诊住院医师同时独立评估。

主要发现

  • 急诊住院医师与血管神经科专科医师的一致性为κ=0.68(95%CI 0.49-0.87)。
  • 急诊住院医师与血管神经科主治医师的一致性为κ=0.69(95%CI 0.50-0.87)。
  • 卒中模拟病是分歧的主要原因,急诊住院医师与血管神经科专科医师在模拟病上的一致性为κ=0.24(95%CI -0.15至0.63)。
  • 所有接受tPA治疗的患者均无并发症。

关键数值与推荐

  • 急诊住院医师与血管神经科专科医师的tPA治疗决策一致性κ=0.68(95%CI 0.49-0.87)。
  • 急诊住院医师与血管神经科主治医师的一致性κ=0.69(95%CI 0.50-0.87)。
  • 卒中模拟病的一致性:与专科医师κ=0.24(95%CI -0.15至0.63),与主治医师κ=0.35(95%CI -0.08至0.78)。

临床怎么用

  • 急诊医师可使用tPA筛查核查表辅助急性卒中患者的tPA治疗决策。
  • 需加强卒中模拟病的识别以进一步提高决策准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- There is uncertainty among many emergency medicine physicians about the decision to give intravenous tPA (tissue-type plasminogen activator), which limits its use. A checklist approach has been suggested as a solution. We compared agreement on tPA treatment in suspected acute ischemic stroke patients between emergency medicine residents (EMRs) using a checklist and vascular neurology fellows (VNFs). Methods- Every suspected acute stroke patient brought to our comprehensive stroke center emergency room within 4.5 hours from symptom onset was prospectively evaluated simultaneously and independently by VNFs and EMRs. The latter used a tPA screening checklist, which included guideline exclusion criteria to help with their treatment decision. Agreement was determined using kappa (k) statistics. Results- Over 6 months, 60 patients were enrolled; 10% large vessel atherosclerosis, 18% cardioembolism, 12% small vessel, 12% cryptogenic, and 47% mimic. Forty-two percent were deemed tPA eligible by the EMR, 30% by the VNF, and 37% by the vascular neurology faculty. There were no complications in any tPA-treated patients. Agreement was substantial between EMR and VNF (κ=0.68 [95% CI, 0.49-0.87]) and between EMR and vascular neurology faculty (κ=0.69 [95% CI, 0.50-0.87]). Stroke mimics were the main cause of disagreement between EMR and VNF (κ=0.24 [95% CI, -0.15 to 0.63]) and between EMR and vascular neurology faculty (κ=0.35 [95% CI, -0.08 to 0.78]). Conclusions- Our data suggest that with the aid of a checklist, EMRs can accurately treat stroke patients with tPA. Areas for improvement include recognition of stroke mimics. Further studies are warranted to evaluate checklist-enhanced tPA treatment to allay emergency medicine physician uncertainty and expand the use of tPA.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Berekashvili K, Zha AM, Abdel-Al M, et al. Emergency Medicine Physicians Accurately Select Acute Stroke Patients for Tissue-Type Plasminogen Activator Treatment Using a Checklist. Stroke. 2019. PMID: 31771461. doi:10.1161/STROKEAHA.119.026948

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。